FDA Summer Clinical Pharmacology Research Fellowship
*Applications will be reviewed on a rolling-basis.
MUST APPLY THROUGH EXTERNAL LINK. MUST SUBMIT RESUME WITH APPLICATION.
Multiple summer research opportunities are available in the Office of Translational Sciences/Office of Clinical Pharmacology, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
The Office of Clinical Pharmacology (OCP) at FDA examines multiple patient factors, alone or in concert, and their effect on drug disposition (for example: age, gender, genetics, organ dysfunction, drug-drug interactions, etc). Under the guidance of a mentor, the participant will learn about policy evaluations that will advance new drug development and/or promote therapeutic individualization. The participant will engage with the mentor in regulatory science research efforts to support development of both scientific and regulatory policy for the Office of Clinical Pharmacology. Activities may include literature review, analysis of existing and proposed policy, and/or construction of knowledge base to store research data and inform further investigations.
We anticipate having multiple research opportunities available for graduate students in Pharmacy or Pharmaceutical Sciences to engage in research projects on topics relevant to OCP scientific needs. Participants will gain hands-on experience with regulatory research projects under the guidance of an expert OCP mentor, utilizing actual data to address real problems, in a stimulating, collaborative, and supportive environment.
Both full-time and part-time appointments are available. Anticipated start date is on or around June 1, 2020 but can be negotiated with the mentor to commence on any Monday throughout the summer in order to best align with school and/or vacation schedules.
To avoid conflict of interest, participants cannot be placed in the same CDER program office where a relative works.
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for three months, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment can be full-time or part-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
Qualifications
The qualified candidate should have received a master's degree in one of the relevant fields, or be currently pursuing a master's or doctoral degree. Completion of doctoral prequalifying exams is preferred. Degree must have been received within five years of the appointment start date.
If you have questions, send an email to ORISE.FDA.CDER@orau.org. Please include the reference code for this opportunity (FDA-CDER-2020-0549) in your email.